Case number 1:19-cv-00177
Genentech, Inc. et al v. Alembic Pharmaceuticals, Ltd., et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2020 | 20 | Motion for Leave to Appear Pro Hac Vice (3) |
| Jul 9, 2020 | 12 | Motion for Leave to Appear Pro Hac Vice (2) |
| Jan 7, 2020 | 21 | Patent/Trademark Report to Commissioner (2) |
| Jan 7, 2020 | 21 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1; 7,635,707 B1; 7,767,700 B2; 7,816,383 B1; 7,910,610 B1; 8,013,002 B2; 8,084,475 B2; 8,318,780 B2; 8,383,150 B2; 8,420,674 B2; 8,592,462 B2; 8,609,701 B2; 8,648,098 B2; 8,754,109 B2; 8,778,947 B2. (Attachments: # (1) Order (D.I. 94 in Lead Civil Action 19-78-RGA)). (nms) |
| Jan 7, 2020 | 21 | Order (D.I. 94) (2) |
| Jan 2, 2020 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per entry of D.I. 94 in Lead Civil Action 19-78-RGA. (nms) |
| Sep 20, 2019 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notices of Service filed at D.I. 18 and 21 have been removed from the docket. Filings are to be made in the Lead Civil Action only. (nms) |
| Sep 17, 2019 | 20 | Main Document (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Cindy Chang and Kevin Dejong - filed by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc., Lek Pharmaceuticals d.d., Sandoz AG, Sandoz International GmbH, Sandoz, Inc.. (Attachments: # (1) Certification of Cindy Chang, # (2) Certification of Kevin DeJong)(Brauerman, Stephen) |
| Sep 17, 2019 | 20 | Certification of Kevin DeJong (1) |
| Sep 17, 2019 | 20 | Certification of Cindy Chang (1) |
| Sep 17, 2019 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (30 in 19-cv-203-RGA, 21 in 19-cv-136-RGA, 30 in 19-cv-202-RGA, 20 in 19-cv-177-RGA) MOTION for Pro Hac Vice Appearance of Attorney Cindy Chang and Kevin Dejong, filed by Lek Pharmaceuticals d.d., Sandoz AG, Alembic Pharmaceuticals, Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Teva Pharmaceuticals USA, Inc., Alembic Global Holding SA, Sandoz, Inc., Alembic Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 9/17/2019. Associated Cases: 1:19-cv-00136-RGA, 1:19-cv-00177-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA(nms) |
| Sep 6, 2019 | 19 | Transcript (41) Docket Text: Official Transcript of Scheduling Conference held on 08/20/19 before Judge Richard G. Andrews. Court Reporter/Transcriber Heather M. Triozzi,Telephone number 302-573-6195. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 9/27/2019. Redacted Transcript Deadline set for 10/7/2019. Release of Transcript Restriction set for 12/5/2019. (Triozzi, Heather) |
| Sep 3, 2019 | 17 | Scheduling Order (16) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Fact Discovery completed by 11/12/2020. Joint Claim Construction Brief due by 8/26/2020. A Markman Hearing is set for 9/23/2020, at 8:30 AM in Courtroom 6A. A Pretrial Conference is set for 10/22/2021, at 8:30 AM in Courtroom 6A. A Bench Trial is set for 11/8/2021, at 9:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/30/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| Sep 3, 2019 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Sherry R. Fallon for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:19-cv-00078-RGA et al.(cak) |
| Aug 30, 2019 | 16 | Main Document (19) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/30/2019 (nms). |
| Aug 30, 2019 | 16 | Cover Letter (1) |
| Aug 30, 2019 | 16 | Proposed Order (19) |
| Aug 20, 2019 | N/A | Scheduling Conference (0) Docket Text: Minute Entry for proceedings held before Judge Richard G. Andrews - Scheduling Conference held on 8/20/2019. Local counsel present for plaintiffs: J. Blumenfeld. Local counsel present for defendants: S. Brauerman, A. Orlacchio, S. O'Byrne, S. Stamoulis, A. Gaza, E. Ormerod, B. Schladweiler, J. Parshall, M. Haney, K. Dorsney. (Court Reporter Heather Triozzi.) Associated Cases: 1:19-cv-00078-RGA et al.(crb) |
| Aug 16, 2019 | 15 | Main Document (26) Docket Text: PROPOSED Scheduling Order, by Genentech, Inc., InterMune, Inc.. (Attachments: # (1) Letter)(Jacobs, Karen) Modified on 8/20/2019 (nms). |
| Aug 16, 2019 | 15 | Letter to The Honorable Richard G. Andrews (2) |
| Aug 16, 2019 | 15 | Proposed Order (26) |
| May 16, 2019 | N/A | Oral Order (0) Docket Text: ORAL ORDER SETTING RULE 16(b) CONFERENCE: A scheduling conference pursuant to Fed. R. Civ. P. 16(b) will be held on Tuesday, August 20, 2019, at 2:30 p.m., in Courtroom 6A of the Boggs Federal Building, 844 King Street, Wilmington, Delaware. Plaintiffs counsel shall coordinate a dial in number for all parties wishing to participate, but not physically being able to do so. The dial in number will be for listening capacity only. Parties shall confer about scheduling and discovery limitations, and attempt to reach agreement. The parties shall use as a basis for discussion the Courts Rule 16 Scheduling Order patent, available on the Courts website. No later than 48 hours before the scheduling conference, the parties shall file a proposed scheduling order using the Rule 16 Scheduling Order - patent. The parties shall direct any requests or questions regarding the scheduling or management of this case to the Courts Case Manager at (302) 573-6137. Ordered by Judge Richard G. Andrews on 5/16/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms) |
| May 16, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Elaine H. Blais, Natasha E. Daughtrey, Emily L. Rapalino, and Srikanth K. Reddy for Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., and Alembic Pharmaceuticals, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg) |
| Apr 5, 2019 | 13 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and Counterclaims, by Genentech, Inc., InterMune, Inc..(Jacobs, Karen) Modified on 4/8/2019 (nms). |
| Mar 27, 2019 | N/A | SO ORDERED (0) |
| Mar 26, 2019 | 12 | Certification of Emily L. Rapalino (1) |
| Mar 26, 2019 | 12 | Certification of Srikanth K. Reddy (1) |
| Mar 26, 2019 | 12 | Certification of Elaine Herrmann Blais (1) |
| Mar 26, 2019 | 12 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Elaine Herrmann Blais, Natasha E. Daughtrey, Emily L. Rapalino, and Srikanth K. Reddy - filed by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd.. (Attachments: # (1) Certification of Elaine Herrmann Blais, # (2) Certification of Natasha E. Daughtrey, # (3) Certification of Emily L. Rapalino, # (4) Certification of Srikanth K. Reddy)(Brauerman, Stephen) |
| Mar 26, 2019 | 12 | Certification of Natasha E. Daughtrey (1) |
| Mar 15, 2019 | 11 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Alembic Pharmaceuticals, Ltd., Corporate Parent Alembic Global Holdings S/A for Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd. filed by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd.. (Brauerman, Stephen) |
| Mar 15, 2019 | 10 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint, and Defenses, by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd..(Brauerman, Stephen) Modified on 3/18/2019 (nms). |
| Mar 8, 2019 | N/A | Add Attorneys Pro Hac Vice (0) |
| Feb 12, 2019 | N/A | SO ORDERED (0) |
| Feb 12, 2019 | N/A | SO ORDERED (0) |
| Feb 11, 2019 | 9 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Defendants to Respond to the Complaint to March 15, 2019 - filed by Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd.. (Brauerman, Stephen) |
| Feb 11, 2019 | 8 | Motion for Leave to Appear Pro Hac Vice (15) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen) |
| Feb 6, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb) |
| Jan 31, 2019 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by InterMune, Inc., Genentech, Inc.. Alembic Pharmaceuticals, Inc. served on 1/30/2019, answer due 2/20/2019. (Blumenfeld, Jack) |
| Jan 31, 2019 | 6 | Declaration (9) Docket Text: DECLARATION of Mailing, by Genentech, Inc., InterMune, Inc.. (Blumenfeld, Jack) Modified on 2/6/2019 (nms). |
| Jan 30, 2019 | N/A | Summons Reissued (0) Docket Text: Summons Reissued with Magistrate Consent Notice attached as to Alembic Pharmaceuticals, Ltd. (nmg) |
| Jan 29, 2019 | 1 | Complaint (43) |
| Jan 29, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alembic Global Holding SA on 1/29/2019; Alembic Pharmaceuticals, Inc. on 1/29/2019; Alembic Pharmaceuticals, Ltd. on 1/29/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ceg) |
| Jan 29, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Genentech, Inc. for InterMune, Inc.; Other Affiliate Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc., InterMune, Inc. (ceg) |
| Jan 29, 2019 | 1 | Main Document (43) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against Alembic Global Holding SA, Alembic Pharmaceuticals, Inc., Alembic Pharmaceuticals, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-255818.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: # (1) Exhibits 1-15, # (2) Civil Cover Sheet)(ceg) |
| Jan 29, 2019 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): See Attached (ceg) Modified on 1/30/2019 (ceg). |
| Jan 29, 2019 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/21/2018. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 4/15/2022. (ceg) |
| Jan 29, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ceg) |
| Jan 29, 2019 | 1 | Civil Cover Sheet (2) |
| Jan 29, 2019 | 1 | Exhibits 1-15 (217) |
| Jan 29, 2019 | 1 | Complaint* (1) |
